| Market Cap | 12.91B |
| Revenue (ttm) | 2.61B |
| Net Income (ttm) | 451.74M |
| Shares Out | n/a |
| EPS (ttm) | 2.16 |
| PE Ratio | 28.58 |
| Forward PE | 16.86 |
| Dividend | 1.38 (2.82%) |
| Ex-Dividend Date | May 19, 2025 |
| Volume | 100 |
| Average Volume | 13 |
| Open | 49.00 |
| Previous Close | 56.04 |
| Day's Range | 49.00 - 56.04 |
| 52-Week Range | 49.00 - 56.04 |
| Beta | 0.53 |
| RSI | 70.04 |
| Earnings Date | May 8, 2025 |
About RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ... [Read more]
Financial Performance
In 2024, RCDTF's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.
Financial numbers in EUR Financial StatementsNews
Recordati reports Q1 results
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%
Milan, 8 th May 2025 – The Board of Directors of Recordati S.p.A. approved the Group's Interim Report as of 31st March 2025, representing additional voluntary financial reporting(7). The Report was pr...
Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase
Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune disorder drug, Enjaymo.
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2024 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q3 2024 Earnings Conference Call November 8, 2024 10:00 AM ET Company Participants Eugenia Litz - VP & Head, Investor Relations Robert K...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2024 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q1 2024 Earnings Conference Call July 30, 2024 10:00 AM ET Company Participants Eugenia Litz - Vice President of Investor Relations of R...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q2 2023 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q2 2023 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2023 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q1 2023 Earnings Conference Call May 11, 2023 10:00 AM ET Company Participants Federica De Medici – Director Investor Relations & Corpor...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q4 2022 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q4 2022 Earnings Conference Call February 21, 2023 10:00 AM ET Company Participants Andrea Recordati - Chairman Rob Koremans - Chief Exe...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2022 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q3 2022 Earnings Conference Call November 8, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations & Corporate C...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q2 2022 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q2 2022 Results Conference Call July 28, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations & Corporate Commu...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q1 2022 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q1 2022 Results Conference Call May 10, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations & Corporate Commun...
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q4 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q4 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q3 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q3 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q2 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q2 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q1 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q1 2021 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q4 2020 Results - Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Andrea Recordati on Q4 2020 Results - Earnings Call Transcript
5 High-Quality Stocks in the Mediterranean
According to the High Quality Screener, a Premium All-in-One Screener template, five high-quality stocks based in Mediterranean countries are Diasorin SpA (MIL:DIA), Koza Altin Izletmeleri AS (IST:KOZ...